Clinical Trial Update: Evaluation of Metabolic Profile of OC000459 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the metabolic profile of OC000459 in asthma; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• OC000459

Snippet

Sponsor: Atopix Therapeutics, Ltd. | Conditions: Asthma | Phase 1 | Status: COMPLETED